Hansen & Associates Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
945
-157
-14% -$160K 0.65% 33
2026
Q1
$1.03M Sell
1,102
-338
-23% -$343K 0.56% 30
2025
Q4
$1.48M Buy
1,440
+167
+13% +$160K 0.81% 29
2025
Q3
$1.26M Buy
+1,273
New +$947K 0.53% 34

Other funds holding LLY

Hansen & Associates Financial Group's LLY Position: Q2 2026 in Review

Hansen & Associates Financial Group reduced its Eli Lilly (LLY) stake by 14% in Q2 2026, selling an estimated $160K and leaving 945 shares worth $1.13M. The position accounts for 0.65% of the portfolio, ranked #33.

Hansen & Associates Financial Group first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.48M in Q4 2025. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hansen & Associates Financial Group held 945 shares of Eli Lilly worth $1.13M as of Q2 2026.
  • Hansen & Associates Financial Group sold 157 Eli Lilly shares in Q2 2026, an estimated $160K.
  • Eli Lilly made up 0.65% of Hansen & Associates Financial Group's portfolio in Q2 2026, its #33 holding.
  • Hansen & Associates Financial Group first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • Hansen & Associates Financial Group's Eli Lilly position peaked at $1.48M in Q4 2025.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hansen & Associates Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.